Code | 2125C | ||||||||||
MA number | 44/0377/10-S | ||||||||||
Product Form: | sol ijf 1x50 ml/100 mg (liek.inj.skl.s modrým viečkom) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous and intravesical use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 08.06.2010 |
SPC: | SPC_Epiribicin Accord 2 mg/ml_11/2019.doc.doc |
PIL: | PIL_Epirubicin Accord 2 mg_ml_11.2021.pdf |
Safety feature | Yes |
Data update: | 13.11.2019 |